A

Alychlo

Marc Coucke's family office, investing across tech, pharma, and food from a base in Merelbeke.

1 Person on the graph8 News mentions

Overview

Alychlo is the family office of Marc Coucke, the Belgian entrepreneur known for building and selling Omega Pharma to Perrigo in 2014. The vehicle has since been deployed across a broad range of sectors including technology, pharmaceuticals, and food.

Alychlo backed Entourage, the Ghent SaaS fund founded by Pieterjan Bouten, signaling continued appetite for Belgian tech exposure. Portfolio companies include SOPHiA GENETICS and miDiagnostics, both in the life sciences space.

Portfolio

  • SOPHiA GENETICS - AI-powered clinical genomics
  • miDiagnostics - Rapid diagnostics

Key people

Investments

  • miDiagnostics

    miDiagnostics is a Belgian medtech Company Building compact diagnostic equipment, having raised $31.5M in a Series D round in December 2024, with Alychlo among its investors.

  • SOPHiA GENETICS

    SOPHiA GENETICS is a publicly traded genomics and data-driven medicine company with Belgian roots and Swiss operations, backed by Alychlo, that applies AI to clinical genomic data analysis.

In the news

Backers

  • Sam Heymans

    Sam Heymans is CEO and co-founder of Lizy, a Brussels-based EV leasing platform that has raised EUR 75M with backing from D'Ieteren and Alychlo.

Something wrong or missing? Send an update. Fixed within 24 hours.